Karmanos Cancer Institute Karmanos Cancer Institute (2) — Detroit, Michigan

Karmanos Cancer Institute Karmanos Cancer Institute (2) is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Karmanos Cancer Institute Karmanos Cancer Institute (2) has participated in 1 clinical trials.

Therapeutic areas: Advanced Breast Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Karmanos Cancer Institute Karmanos Cancer Institute (2)?

Karmanos Cancer Institute Karmanos Cancer Institute (2) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Karmanos Cancer Institute Karmanos Cancer Institute (2) conducted?

Karmanos Cancer Institute Karmanos Cancer Institute (2) has 1 clinical trials on record. Their work covers Advanced Breast Cancer.

Is Karmanos Cancer Institute Karmanos Cancer Institute (2) accredited by Crixeo Health?

Karmanos Cancer Institute Karmanos Cancer Institute (2) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Karmanos Cancer Institute Karmanos Cancer Institute (2)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.